Altavista Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Altavista Wealth Management's GILD Position: Q1 2018 in Review
Altavista Wealth Management sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 3,511 shares — an estimated $252K sold.
Altavista Wealth Management first reported a position in GILD in Q2 2013 and held it in 19 quarters. The position peaked at $666K in Q1 2014. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.
- Altavista Wealth Management reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
- Altavista Wealth Management sold 3,511 Gilead Sciences shares in Q1 2018, an estimated $252K.
- Altavista Wealth Management first reported a position in Gilead Sciences in Q2 2013 and held it in 19 quarters.
- Altavista Wealth Management's Gilead Sciences position peaked at $666K in Q1 2014.
- 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.
Based on Altavista Wealth Management's 13F filing for Q1 2018, filed 16 May 2018.